Probiotics in human immunodeficiency virus infection: A systematic review and evidence synthesis of benefits and risks

Open Forum Infectious Diseases

Volumn 3, Issue 4, 2016, Pages

  Carter, George M ^a   Esmaeili, Aryan ^b   Shah, Hardikkumar ^b   Indyk, Debbie ^b   Johnson, Matthew ^c   Andreae, Michael ^d   Sacks, Henry S ^b  

^a Found for Integrative AIDS Research   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c Icahn School of Medicine at Mount Sinai ^*  (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Bacteremia; Fungemia; HIV infection; Probiotics

Indexed keywords

ANTIRETROVIRUS AGENT; PROBIOTIC AGENT;

BACTEREMIA; CD4 LYMPHOCYTE COUNT; CLOSTRIDIUM DIFFICILE INFECTION; DIARRHEA; DIETARY SUPPLEMENT; FUNGEMIA; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEPSIS; SYSTEMATIC REVIEW; VAGINITIS;

EID: 84996538572     PISSN: None     EISSN: 23288957     Source Type: Journal    
DOI: 10.1093/ofid/ofw164     Document Type: Review

References (75)

1. Lorenc A, Robinson N. A review of the use of complementary and alternative medicine and HIV: issues for patient care. AIDS Patient Care STDS 2013; 27:503-10
2. Reid G, Anand S, Bingham MO, et al. Probiotics for the developing world. J Clin Gastroenterol 2005; 39:485-8
3. Gonzalez-Hernandez LA, Jave-Suarez LF, Fafutis-Morris M, et al. Synbiotic therapy decreases microbial translocation and inflammation and improves immunological status in HIV-infected patients: a double-blind randomized controlled pilot trial. Nutr J 2012; 11:90
4. Douek DC, Roederer M, Koup RA. Emerging concepts in the immunopathogenesis of AIDS. Annu Rev Med 2009; 60:471-84
5. Zareie M, Johnson-Henry K, Jury J, et al. Probiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress. Gut 2006; 55:1553-60
6. Bolton M, van der Straten A, Cohen CR. Probiotics: potential to prevent HIV and sexually transmitted infections in women. Sex Transm Dis 2008; 35:214-25
7. Guinane S. The effectiveness of probiotics for managing diarrhoea in people with HIV infection: a critically appraised topic. HIV Med 2013; 14:187-90
8. Salari P, Nikfar S, Abdollahi M. A meta-analysis and systematic review on the effect of probiotics in acute diarrhea. Inflamm Allergy Drug Targets 2012; 11:3-14
9. McFarland LV. Probiotics for the primary and secondary prevention of C. difficile infections: a meta-analysis and systematic review. Antibiotics (Basel) 2015; 4:160-78
10. Sleator RD. Probiotics - a viable therapeutic alternative fosr enteric infections especially in the developing world. Discov Med 2010; 10:119-24
11. Williams B, Landay A, Presti RM. Microbiome alterations in HIV infection a review. Cell Microbiol 2016; 18:645-51
12. Enos MK, Burton JP, Dols J, et al. Probiotics and nutrients for the first 1000 days of life in the developing world. Benef Microbes 2013; 4:3-16
13. Szajewska H, Kolodziej M. Systematic review with meta-analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic-associated diarrhoea in children and adults. Aliment Pharmacol Ther 2015; 42:1149-57
14. Li BZ, Threapleton DE,Wang JY, et al. Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis. BMJ 2015; 351:h4052
15. Wilson NL, Moneyham LD, Alexandrov AW. A systematic review of probiotics as a potential intervention to restore gut health in HIV infection. J Assoc Nurses AIDS Care 2013; 24:98-111
16. Doron S, Snydman DR. Risk and safety of probiotics. Clin Infect Dis 2015; 15: S129-34
17. Sacks HS, Carter GM, Indyk D, et al. Probiotic supplementation in HIV disease: Bayesian and systematic meta-analyses. PROSPERO CRD42013004766. 2013. Available at: http://www.crd.york.ac.uk/PROSPERO/display_record.asp? ID=CRD42013004766. Accessed 19 August 2016
18. Gori A, Rizzardini G, Van't Land B, et al. Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: results of the "COPA" pilot randomized trial. Mucosal Immunol 2011; 4:554-63
19. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions 5.1.0 [updated March 2011]. The Cochrane Collaboration 2011. Available at: http://handbook.cochrane.org/. Accessed 19 August 2016
20. Saint-Marc T, Rossello-Prats L, Touraine JL. Efficacy of Saccharomyces boulardii in the treatment of diarrhea in AIDS. Ann Med Interne (Paris) 1991; 142:64-5
21. Irvine SL, Hummelen R, Hekmat S. Probiotic yogurt consumption may improve gastrointestinal symptoms, productivity, and nutritional intake of people living with human immunodeficiency virus in Mwanza, Tanzania. Nutr Res 2011; 31:875-81
22. Fu R, Gartlehner G, Grant M, et al. Conducting quantitative synthesis when comparing medical interventions: AHRQ and the Effective Health Care Program. J Clin Epidemiol 2011; 64:1187-97
23. Gautam N, Dayal R, Agarwal D, et al. Role of multivitamins, micronutrients and probiotics supplementation in management of HIV infected children. Indian J Pediatr 2014; 81:1315-20
24. Kerac M, Bunn J, Seal A, et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double-blind efficacy randomised controlled trial in Malawi. Lancet 2009; 374:136-44
25. Schunter M, Chu H, Hayes TL, et al. Randomized pilot trial of a synbiotic dietary supplement in chronic HIV-1 infection. BMC Complement Altern Med 2012; 12:84
26. Villar-García J, Hernández JJ, Güerri-Fernández R, et al. Effect of probiotics (Saccharomyces boulardii) on microbial translocation and inflammation in HIV-treated patients: a double-blind, randomized, placebo-controlled trial. J Acquir Immune Defic Syndr 2015; 68:256-63
27. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315:629-34
28. Anukam KC, Osazuwa EO, Osadolor HB, et al. Yogurt containing probiotic Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 helps resolve moderate diarrhea and increases CD4 count in HIV/AIDS patients. J Clin Gastroenterol 2008; 42:239-43
29. Hummelen R, Changalucha J, Butamanya NL, et al. Effect of 25 weeks probiotic supplementation on immune function of HIV patients. Gut Microbes 2011; 2:80-5
30. Heiser CR, Ernst JA, Barrett JT, French N, et al. Probiotics, soluble fiber, and Lglutamine (GLN) reduce nelfinavir (NFV)- or lopinavir/ritonavir (LPV/r)-related diarrhea. J Int Assoc Physicians AIDS Care (Chic) 2004; 3:121-9
31. Cunningham-Rundles S, Ahrne S, Bengmark S, et al. Probiotics and immune response. Am J Gastroenterol 2000; 95:(1 Suppl)S22-5
32. Cunningham-Rundles S, Ahrne S, Johann-Liang R, et al. Effect of probiotic bacteria on microbial host defense, growth, and immune function in human immunodeficiency virus type-1 infection. Nutrients 2011; 3:1042-70
33. Saint-Marc T, Blehaut H, Musial C, Touraine JL. [Diarrhees en relation avec le sida: essai en double aveugle de Saccharomyces boulardii]. Semaine Des Hopitaux 1995; 71:735-41
34. Trois L, Cardoso EM, Miura E. Use of probiotics in HIV-infected children: a randomized double-blind controlled study. J Trop Pediatr 2008; 54:19-24
35. Salminen MK, Tynkkynen S, Rautelin H, et al. The efficacy and safety of probiotic Lactobacillus rhamnosus GG on prolonged, noninfectious diarrhea in HIV patients on antiretroviral therapy: a randomized, placebo-controlled, crossover study. HIV Clin Trials 2004; 5:183-91
36. Hummelen R, Hemsworth J, Changalucha J, et al. Effect of micronutrient and probiotic fortified yogurt on immune-function of anti-retroviral therapy naive HIV patients. Nutrients 2011; 3:897-909
37. Wolf BW, Wheeler KB, Ataya DG, Garleb KA. Safety and tolerance of Lactobacillus reuteri supplementation to a population infected with the human immunodeficiency virus. Food Chem Toxicol 1998; 36:1085-94
38. Irvine SL, Hummelen R, Hekmat S, et al. Probiotic yogurt consumption is associated with an increase of CD4 count among people living with HIV/AIDS. J Clin Gastroenterol 2010; 44:e201-5
39. Yang OO, Kelesidis T, Cordova R, Khanlou H. Immunomodulation of antiretroviral drug-suppressed chronic HIV-1 infection in an oral probiotic double-blind placebo-controlled trial. AIDS Res Hum Retroviruses 2014; 30:988-95
40. Falasca K, Vecchiet J, Ucciferri C, et al. Effect of probiotic supplement on cytokine levels in HIV-infected individuals: a preliminary study. Nutrients 2015; 7:8335-47
41. Hemsworth JC, Hekmat S, Reid G. Micronutrient supplemented probiotic yogurt for HIV-infected adults taking HAART in London, Canada. Gut Microbes 2012; 3:414-9
42. Schunter M, Chu H, Hayes TL, et al. Randomized pilot trial of a synbiotic dietary supplement in chronic HIV-1 infection. BMC Complement Altern Med 2012; 12:84
43. d'Ettorre G, Ceccarelli G, Giustini N, et al. Probiotics reduce inflammation in antiretroviral treated, HIV-infected individuals: results of the "Probio-HIV" clinical trial. PLoS One 2015; 10:e0137200
44. Pirotta M, Fethers KA, Bradshaw CS. Bacterial vaginosis - More questions than answers. Aust Fam Physician 2009; 38:394-7
45. Mirmonsef P, Krass L, Landay A, Spear GT. The role of bacterial vaginosis and trichomonas in HIV transmission across the female genital tract. Curr HIV Res 2012; 10:202-10
46. Hummelen R, Changalucha J, Butamanya NL, et al. Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 to prevent or cure bacterial vaginosis among women with HIV. Int J Gynaecol Obstet 2010; 111:245-8
47. Gori A, Van't Land B, Rizzardini G, et al. Immune activation and gut microbiota can be positively modified in HAART-naive HIV-infected adults by specific prebiotics. HIV Med 2009; 10(suppl 2):120
48. Snydman D. The safety of probiotics. Clin Infect Dis 2008; 46(suppl 2):S104-11
49. Dasopoulou M, Briana DD, Boutsikou T, et al. Motilin and gastrin secretion and lipid profile in preterm neonates following prebiotics supplementation: a double- Blind randomized controlled study. JPEN J Parenter Enteral Nutr 2015; 39:359-68
50. Srinivasjois R, Rao S, Patole S. Prebiotic supplementation in preterm neonates: updated systematic review and meta-analysis of randomised controlled trials. Clin Nutr 2013; 32:958-65
51. Piemontese P, Giannì ML, Braegger CP, et al. Tolerance and safety evaluation in a large cohort of healthy infants fed an innovative prebiotic formula: a randomized controlled trial. PLoS One 2011; 6:e28010
52. Braegger C, Chmielewska A, Decsi T, et al. Supplementation of infant formula with probiotics and/or prebiotics: a systematic review and comment by the ESPGHAN committee on nutrition. J Pediatr Gastroenterol Nutr 2011; 52:238-50
53. Morrow LE, Gogineni V, Malesker MA. Probiotic, prebiotic, and synbiotic use in critically ill patients. Curr Opin Crit Care 2012; 18:186-91
54. Besselink MG, van Santvoort HC, Buskens E, et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 2008; 371:651-9
55. Bongaerts GP, Severijnen RS. A reassessment of the PROPATRIA study and its implications for probiotic therapy. Nat Biotechnol 2016; 34:55-63
56. Van den Nieuwboer M, Brummer RJ, Guarner F, et al. The administration of probiotics and synbiotics in immune compromised adults: is it safe? Benef Microbes 2015; 6:3-17
57. Hempel S, Newberry S, Ruelaz A, et al. Safety of Probiotics to Reduce Risk and Prevent or Treat Disease. Evidence Report/Technology Assessment No. 200. (Prepared by the Southern California Evidence-based Practice Center under Contract No. 290-2007-10062-I.). AHRQ Publication No 11-E007 Rockville, MD: Agency for Healthcare Research and Quality 200, 2011. Available at: http://www.ahrq.gov/clinic/tp/probiotictp.htm Accessed 19 August 2016
58. Reid G, Bocking A. The potential for probiotics to prevent bacterial vaginosis and preterm labor. Am J Obstet Gynecol 2003; 189:1202-8
59. Sarkar S. Potential of probiotics as pharmaceutical agent: a review. British Food Journal 2013; 115:1658-87
60. Hummelen R, Hemsworth J, Reid G. Micronutrients, N-acetyl cysteine, probiotics and prebiotics, a review of effectiveness in reducing HIV progression. Nutrients 2010; 2:626-51
61. Lopez O, Bonnefont-Rousselot D, Edeas M, et al. Could antioxidant supplementation reduce antiretroviral therapy-induced chronic stable hyperlactatemia? Biomed Pharmacother 2003; 57:113-6
62. Louis-Auguste J, Greenwald S, Simuyandi M, et al. High dose multiple micronutrient supplementation improves villous morphology in environmental enteropathy without HIV enteropathy: results from a double-blind randomised placebo controlled trial in Zambian adults. BMC Gastroenterol 2014; 14:15-25
63. Merlini E, Bai F, Bellistri GM, et al. Evidence for polymicrobic flora translocating in peripheral blood of HIV-infected patients with poor immune response to antiretroviral therapy. PLoS One 2011; 6:e18580
64. Lederman MM, Calabrese L, Funderburg NT, et al. Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cells. J Infect Dis 2011; 204:1217-26
65. Marchetti G, Bellistri GM, Borghi E, et al. Microbial translocation is associated with sustained failure in CD4R T-cell reconstitution in HIV- infected patients on long-term highly active antiretroviral therapy. AIDS 2008; 22:2035-44
66. Merlini E, Bai F, Ferramosca S, et al. Characterization of the translocating microflora in peripheral blood of severely immune depressed HIV+ naive patients: may the microbiota influence the response to HAART? In: Infection Conference: Italian Conference on AIDS and Retroviruses, ICAR 2010, 20-22 June 2010, Poster PO 111. Brescia: Italy. Infection 2010; 38(suppl 1):93
67. Vujkovic-Cvijin I, Swain LA, Chu SN, et al. Gut-resident Lactobacillus abundance associates with IDO1 inhibition and Th17 dynamics in SIV-infected macaques. Cell Rep 2015; 13:1589-97
68. Ortiz AM, Klase ZA, DiNapoli SR, et al. IL-21 and probiotic therapy improve Th17 frequencies, microbial translocation, and microbiome in ARV-treated, SIV-infected macaques. Mucosal Immunol 2016; 9:458-67
69. Homayouni A, Bastani P, Ziyadi S, et al. Effects of probiotics on the recurrence of bacterial vaginosis: a review. J Low Genit Tract Dis 2014; 18:79-86
70. Parma M, Stella Vanni V, Bertini M, Candiani M. Probiotics in the prevention of recurrences of bacterial vaginosis. Altern Ther Health Med 2014; 20(suppl 1):52-7
71. Kwok CS, Arthur AK, Anibueze CI, et al. Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis. Am J Gastroenterol 2012; 107:1011-9
72. Mutlu EA, Keshavarzian A, Losurdo J, et al. A compositional look at the human gastrointestinal microbiome and immune activation parameters in HIV infected subjects. PLoS Pathog 2014; 10:e1003829
73. Taguer M, Maurice CF. The complex interplay of diet, xenobiotics, and microbial metabolism in the gut: implications for clinical outcomes. Clin Pharmacol Ther 2016; 99:588-99
74. Kim CJ, Walmsley SL, Raboud JM, Kovacs C, et al. Can probiotics reduce inflammation and enhance gut immune health in people living with HIV: study designs for the probiotic visbiome for inflammation and translocation (PROOV IT) pilot trials. HIV Clin Trials 2016; 17:147-57
75. Carter GM, Indyk D, Johnson M, et al. Micronutrients in HIV: a bayesian metaanalysis. PLoS One 2015; 10:e0120113